82 related articles for article (PubMed ID: 19077160)
1. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
Reismüller B; Attarbaschi A; Peters C; Dworzak MN; Pötschger U; Urban C; Fink FM; Meister B; Schmitt K; Dieckmann K; Henze G; Haas OA; Gadner H; Mann G;
Br J Haematol; 2009 Feb; 144(4):559-70. PubMed ID: 19077160
[TBL] [Abstract][Full Text] [Related]
2. miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment.
Piatopoulou D; Avgeris M; Marmarinos A; Xagorari M; Baka M; Doganis D; Kossiva L; Scorilas A; Gourgiotis D
Br J Cancer; 2017 Sep; 117(6):801-812. PubMed ID: 28787435
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.
Ko RH; Ji L; Barnette P; Bostrom B; Hutchinson R; Raetz E; Seibel NL; Twist CJ; Eckroth E; Sposto R; Gaynon PS; Loh ML
J Clin Oncol; 2010 Feb; 28(4):648-54. PubMed ID: 19841326
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.
Horton TM; Whitlock JA; Lu X; O'Brien MM; Borowitz MJ; Devidas M; Raetz EA; Brown PA; Carroll WL; Hunger SP
Br J Haematol; 2019 Jul; 186(2):274-285. PubMed ID: 30957229
[TBL] [Abstract][Full Text] [Related]
5. T-cell acute lymphoblastic leukemia.
Raetz EA; Teachey DT
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):580-588. PubMed ID: 27913532
[TBL] [Abstract][Full Text] [Related]
6. Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts.
Minuzzo S; Agnusdei V; Pinazza M; Amaro AA; Sacchetto V; Pfeffer U; Bertorelle R; Spinelli O; Serafin V; Indraccolo S
Exp Hematol Oncol; 2023 Sep; 12(1):76. PubMed ID: 37667380
[TBL] [Abstract][Full Text] [Related]
7. BP‑1‑102 exerts antitumor effects on T‑cell acute lymphoblastic leukemia cells by suppressing the JAK2/STAT3/c‑Myc signaling pathway.
Ye C; Ruan X; Zhao Y; Zhu H; Wang C; Cheng Z; Peng H
Exp Ther Med; 2023 May; 25(5):191. PubMed ID: 37020528
[TBL] [Abstract][Full Text] [Related]
8. Growth arrest-specific protein 2 (GAS2) interacts with CXCR4 to promote T-cell leukemogenesis partially via c-MYC.
Ma W; Wan Y; Zhang J; Yao J; Wang Y; Lu J; Liu H; Huang X; Zhang X; Zhou H; He Y; Wu D; Wang J; Zhao Y
Mol Oncol; 2022 Oct; 16(20):3720-3734. PubMed ID: 36054080
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic Hematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukemia: Shifting Indications in the Era of Immunotherapy.
Truong TH; Jinca C; Mann G; Arghirescu S; Buechner J; Merli P; Whitlock JA
Front Pediatr; 2021; 9():782785. PubMed ID: 35004545
[TBL] [Abstract][Full Text] [Related]
10. T-Cell Acute Lymphoblastic Leukemia-Current Concepts in Molecular Biology and Management.
Shiraz P; Jehangir W; Agrawal V
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829849
[TBL] [Abstract][Full Text] [Related]
11. Genetic Alterations in Childhood Acute Lymphoblastic Leukemia: Interactions with Clinical Features and Treatment Response.
Lee SHR; Li Z; Tai ST; Oh BLZ; Yeoh AEJ
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439222
[TBL] [Abstract][Full Text] [Related]
12. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract][Full Text] [Related]
13. CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study.
Qian JJ; Hu X; Wang Y; Zhang Y; Du J; Yang M; Tong H; Qian WB; Wei J; Yu W; Lou YJ; Mao L; Tao Meng H; You LS; Wang L; Li X; Huang X; Cao LH; Zhao JZ; Yan Yan X; Chen YB; Chen Y; Zhang SJ; Jin J; Hu J; Zhu HH
Cancer Med; 2020 Aug; 9(15):5327-5334. PubMed ID: 32492289
[TBL] [Abstract][Full Text] [Related]
14. Harnessing immunotherapy for pediatric T-cell malignancies.
Diorio C; Teachey DT
Expert Rev Clin Immunol; 2020 Apr; 16(4):361-371. PubMed ID: 32103690
[TBL] [Abstract][Full Text] [Related]
15. Relapsed T Cell ALL: Current Approaches and New Directions.
McMahon CM; Luger SM
Curr Hematol Malig Rep; 2019 Apr; 14(2):83-93. PubMed ID: 30880359
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness Analysis of an Adherence-Promotion Intervention for Children With Leukemia: A Markov Model-Based Simulation.
McGrady ME; Eckman MH; O'Brien MM; Pai ALH
J Pediatr Psychol; 2018 Aug; 43(7):758-768. PubMed ID: 29771338
[TBL] [Abstract][Full Text] [Related]
17. Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study.
Barredo JC; Hastings C; Lu X; Devidas M; Chen Y; Armstrong D; Winick N; Wood BL; Yanofsky R; Loh M; Gastier-Foster JM; Jorstad DT; Marcus R; Ritchey K; Carrol WL; Hunger SP
Pediatr Blood Cancer; 2018 May; 65(5):e26928. PubMed ID: 29286562
[TBL] [Abstract][Full Text] [Related]
18. A novel
Zabriskie MS; Antelope O; Verma AR; Draper LR; Eide CA; Pomicter AD; Tran TH; Druker BJ; Tyner JW; Miles RR; Graham JM; Hwang JY; Varley KE; Toydemir RM; Deininger MW; Raetz EA; O'Hare T
Haematologica; 2018 Feb; 103(2):e87-e91. PubMed ID: 29284681
[No Abstract] [Full Text] [Related]
19. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.
Chow YP; Alias H; Jamal R
BMC Cancer; 2017 Feb; 17(1):120. PubMed ID: 28183295
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
